However, no significant differences were detected in other outcomes, including nonmotor symptoms, cognition, finger tapping, walking speed, and levodopa equivalent dose [97]
It is not a quick fix, and it is not the right choice for every patient
It will be interesting to see where healthcare organizations land on some of these questions, since many are in the unique position of both sponsoring health coverage and providing actual care to their employees
39:1115-1122 [PubMed: 27289124] 183
The Cost vs Pharmaceutical Comparison A common comparison Canadian researchers consider: retatrutide research peptide cost vs pharmaceutical metabolic peptide products
Tirzepatide once weekly for treatment of obesity